|
CN111253330A
|
|
Novel crystal form of sartan drug, preparation method and application thereof
|
|
CN110787136A
|
|
Preparation method of cefpodoxime proxetil preparation
|
|
CN110627813A
|
|
Preparation method of cefuroxime axetil methoxyimino isomer
|
|
CN110627814A
|
|
Preparation method of cefuroxime sodium methoxyimino isomer
|
|
CN110590811A
|
|
Preparation method of cefuroxime axetil-3-ene isomer
|
|
CN110452240A
|
|
Eliquis crystal form and preparation method thereof
|
|
CN110339178A
|
|
A kind of preparation method of clopidogrel bisulfate solid preparation
|
|
CN109851627A
|
|
A kind of preparation method of Cefuroxime Sodium crystal-form compound
|
|
CN109481415A
|
|
A kind of Cefdinir capsule agent and preparation method thereof
|
|
CN108578404A
|
|
A kind of Pharmaceutical composition and preparation method thereof containing Irbesartan and Amlodipine
|
|
CN107890460A
|
|
A kind of trinosin composition powder injection
|
|
CN108129550A
|
|
A kind of crystal form of reduced glutathione and preparation method thereof
|
|
CN107880083A
|
|
A kind of process for purification of clindamycin phosphate
|
|
CN107951842A
|
|
A kind of preparation method of micro mist cefpiramide
|
|
CN107308157A
|
|
A kind of compound oral solid pharmaceutical preparation containing clopidogrel and preparation method thereof
|
|
CN106632135A
|
|
Preparation method and application of thiazole acetyl glycine oxime acetaldehyde dimethyl ether
|
|
CN106674151A
|
|
Preparation method and application of thiazolylacetylglycine oxime
|
|
CN105017173A
|
|
Cefotiam impurity A derivative preparation method
|
|
CN104892536A
|
|
N-(2, 2-dimethoxyethyl)-2-(1H-tetrazol-1-yl) amide and its preparation method
|
|
CN104447285A
|
|
Novel crystal form of calcium levulinate monohydrate
|
